BeStock  
Stocks › Biotechnology › PBYI

Puma Biotechnology PBYI

US equityMarket cap rank #3692Biotechnology
$7.05 −$0.07 (-0.98%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $7.05 0.00%
Open$7.05
Prev close$7.12
Day range$6.91 – $7.22
Volume861.2K
Market cap$364.47M
P/E (TTM)15.3
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership78.5%+1.68 pts vs. prior quarter
Institutions holding194-2 vs. prior quarter
Insider trades (recent)13 buys / 37 sellsNet selling
Short interest8.33% of floatDays to cover 11.5 · as of 30 Oct 2026
Short-sale volume share26.1%5-day average of daily volume

Short-sale volume as % of daily volume

15%21%28%34%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$1.43M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

−$1.0MSuper−$428.9KBig−$474.3KMid−$515.6KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 37.9% of shares outstanding.

Largest holders

  • Alan Auerbach12.38%
  • BlackRock8.14%
  • Acorn Bioventures7.99%
  • American Century Investment Management5.31%
  • Acadian Asset Management LLC4.03%
  • LSV Asset Management3.75%
  • Vanguard Portfolio Management, LLC3.66%
  • Renaissance Technologies Corp.3.65%

By investor type

  • Mutual Fund59.21%
  • Individual/Insider13.82%
  • VC/PE Fund7.99%
  • Hedge Fund7.39%
  • Public Company1.51%
  • Government Pension Fund1.35%
  • Private Company0.53%
  • Family Office/Trust0.43%

Reported short interest has risen from 8.07% to 8.33% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
American Century Investment Management Mutual Fund 2026/Q3 +422,657 5.3%
BlackRock Mutual Fund 2026/Q3 +402,445 8.1%
LSV Asset Management Mutual Fund 2026/Q3 +323,120 3.8%
Morgan Stanley Public Company 2026/Q3 +165,918 0.8%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +165,918 0.8%
SummerHaven Investment Management, LLC Mutual Fund 2026/Q3 +114,315 0.2%
Federated Hermes, Inc. Mutual Fund 2026/Q3 +84,867 0.6%
Legato Capital Management, LLC Mutual Fund 2026/Q3 +83,190 0.2%
Los Angeles Capital Management LLC Mutual Fund 2026/Q3 +81,019 0.2%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +67,680 3.7%
OpenArc Corporate Advisory, LLC Family Office/Trust 2026/Q3 +60,133 0.2%
FMR Mutual Fund 2026/Q3 +55,734 0.5%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +47,800 3.6%
First Trust Advisors L.P. Mutual Fund 2026/Q3 +42,421 0.3%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +59,119 0.1%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
10 Nov 2026 Michael Miller Independent Director Intent to Sell (Form 144) -15,000 $8.10 –
13 Sep 2026 Troy Wilson Independent Director Open Market Disposition -5,000 $9.10 28,300
13 Sep 2026 Alessandra Cesano Independent Director Open Market Disposition -12,150 $9.12 29,700
13 Sep 2026 Alessandra Cesano Independent Director Derivative Exercise and Sale -50,000 $9.12 29,700
5 Jul 2026 Alan Auerbach Founder, Chairman, President, CEO & Secretary Automatic Disposition -44,058 $8.26 7,092,238
5 Jul 2026 Douglas Hunt Chief Regulatory Affairs, Medical Affairs, Pharmacovigilance & Law Officer Automatic Disposition -8,460 $8.26 147,766
5 Jul 2026 Maximo Nougues Chief Financial Officer Automatic Disposition -9,386 $8.26 180,219
11 Jun 2026 Jay Moyes Lead Independent Director Automatic Disposition -22,000 $7.22 31,322
11 Jun 2026 Troy Wilson Independent Director Automatic Disposition -10,800 $7.20 33,300
11 Jun 2026 Adrian Senderowicz Independent Director Automatic Disposition -27,000 $7.20 –
11 Jun 2026 Allison Dorval Independent Director Automatic Disposition -11,610 $7.20 63,780
11 Jun 2026 Brian Stuglik Independent Director Automatic Disposition -8,100 $7.20 86,858
10 Jun 2026 Jay Moyes Lead Independent Director Other Acquisition +27,000 – 27,000
10 Jun 2026 Michael Miller Independent Director Other Acquisition +27,000 – 27,000
10 Jun 2026 Troy Wilson Independent Director Other Acquisition +27,000 – 27,000
10 Jun 2026 Alessandra Cesano Independent Director Other Acquisition +27,000 – 27,000
10 Jun 2026 Adrian Senderowicz Independent Director Other Acquisition +27,000 – 27,000
10 Jun 2026 Allison Dorval Independent Director Other Acquisition +27,000 – 27,000
10 Jun 2026 Brian Stuglik Independent Director Other Acquisition +27,000 – 27,000
17 Feb 2026 Alan Auerbach Founder, Chairman, President, CEO & Secretary Other Acquisition +159,778 – 258,978

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 4,298,038 8.3% 11.5
15 Oct 2026 4,540,314 8.8% 12.9
30 Sep 2026 4,264,923 8.3% 14.0
15 Sep 2026 4,319,663 8.4% 13.8
31 Aug 2026 4,274,524 8.3% 15.6
14 Aug 2026 4,167,830 8.1% 11.4

Discussion

No comments yet — be the first to weigh in on PBYI.

Sign in to join the discussion.

Scroll to Top